Lucy Therapeutics


Lucy Therapeutics is offering a differentiated and novel approach to drug discovery by drugging targets associated with early disease pathogenesis. LucyTx’s unique approach recognizes that improvement of mitochondrial function early in disease will lead to disease modification as opposed to late-sta... Read more

Employees

11-50

Links


Org chart

Collapse
Bryan Keaney
Chief Financial Officer
Allen Hopper
Senior Director, Drug Discovery

Board & advisors

Peter Lansbury
Scientific Advisor
Giovanni Manfredi
Scientific Advisor
John Macor
Scientific Advisor
Nelli Mnatsakanyan
Scientific Advisor
David Rotella
Scientific Advisor
Joanne Bronson
Scientific Advisor
James Summers
Scientific Advisor
Laurie Sanders
Scientific Advisor
John Ripple
Independent Director
Ann DeWitt
Director


Offices